Secondary analyses of data from a former double-blind placebo-controlled trial in which 150 dyslipidemic statin-treated subjects were randomized to four capsules of fish oil daily either as re-esterified TAG or ethyl esters in identical doses ( 1.01 g EPA +0.67 g DHA ) or corn oil as a placebo for a period of six month .